Related by context. All words. (Click for frequent words.) 81 Patients Treated 81 Advanced Melanoma 80 Meets Primary Endpoint 80 Improves Survival 79 Adjuvant Treatment 79 Hormone Refractory Prostate Cancer 79 Adjuvant Therapy 79 Survival Benefit 79 Improved Survival 79 Previously Treated 79 Advanced Renal Cell 79 Metastatic Renal Cell Carcinoma 78 Improves Outcomes 78 Adjuvant Chemotherapy 78 Colorectal Cancer Patients 78 Chronic Hepatitis C 78 Renal Cell Carcinoma 78 Phase III Trial 78 Patients Treated With 78 Previously Untreated 78 Prolongs Survival 78 Advanced Prostate Cancer 78 Newly Diagnosed Multiple Myeloma 78 Advanced Colorectal Cancer 78 Rheumatoid Arthritis Patients 78 Monotherapy 77 HER2 Positive Breast Cancer 77 Phase 2b Clinical Trial 77 Metastatic Prostate Cancer 77 Elderly Patients 77 Malignant Melanoma 77 Anti Tumor Activity 77 Study Showed 77 Severe Sepsis 77 Antitumor Activity 77 Myelodysplastic Syndromes 77 Multiple Myeloma Patients 77 Is Well Tolerated 77 Complicated Skin 76 Study Evaluating 76 Combination Therapy 76 Castration Resistant Prostate Cancer 76 Clinical Trial Results 76 Pooled Analysis 76 Soft Tissue Sarcoma 76 Phase IIb Trial 76 Phase III Clinical Trial 76 Relapsed Refractory 76 Well Tolerated 76 Cutaneous T 76 Relapsed Multiple Myeloma 76 Pivotal Phase 76 Lung Cancer Patients 76 Follicular Lymphoma 76 Trial Evaluating 75 Improve Survival 75 Metastatic Melanoma 75 Bevacizumab 75 Oral Fingolimod 75 Combination Treatment 75 Relapsing Multiple Sclerosis 75 Chronic Myeloid Leukemia 75 Myeloma Patients 75 Pivotal Phase III 75 Randomized Phase 75 Overactive Bladder 75 Peginterferon 75 Prostate Cancer Patients 75 Gastric Cancer 75 Androgen Deprivation Therapy 75 Long Term Efficacy 75 Infected Patients 75 Hormone Receptor Positive 75 Patients Receiving 75 Investigational Treatment 75 Investigational Agent 74 Drug Candidate 74 Chronic Hepatitis B 74 Carboplatin Paclitaxel 74 Advanced Pancreatic Cancer 74 Postmenopausal Women 74 Breast Cancer Recurrence 74 Disease Progression 74 Phase III Trials 74 Heart Failure Patients 74 Advanced Solid Tumors 74 Knee Osteoarthritis 74 Node Positive 74 Gene Mutation 74 Resistant Hypertension 74 Atypical Hemolytic Uremic Syndrome 74 Treatment Naive Patients 74 Advanced Ovarian Cancer 74 Subgroup Analysis 74 Patients Undergoing 74 Cardiovascular Events 74 Statistically Significant 74 Relapsing Remitting Multiple Sclerosis 74 Completes Enrollment 74 Pivotal Study 74 Mouse Model 74 JAK Inhibitor 74 Unfractionated Heparin 74 Hepatitis C Patients 74 Phase 2b Study 74 Diabetic Patients 74 Pegylated Interferon 73 Initiate Phase III 73 Pivotal Trial 73 Autologous Stem Cell Transplantation 73 Anthracycline 73 Pulmonary Arterial Hypertension 73 Sustained Efficacy 73 Completes Patient Enrollment 73 Treated Patients 73 Chronic Sinusitis 73 Appears Safe 73 Localized Prostate Cancer 73 Adjunctive Therapy 73 Investigational Compound 73 Patient Enrollment 73 Chemoradiation 73 Plus Ribavirin 73 Combination REOLYSIN R 73 Hypertensive Patients 73 Clinical Trial Evaluating 73 Unresectable 73 Metastatic Breast Cancer 73 Chemotherapy Improves 73 Hepatocellular Carcinoma 73 Single Dose 73 Statin Therapy 73 Treating Chronic 73 Phase 2b Trial 73 Solid Tumors 73 Refractory Hodgkin Lymphoma 73 Treatment Experienced 73 Shows Efficacy 72 Brain Metastases 72 Complete Remission 72 Acute Ischemic Stroke 72 HER2 Positive 72 Investigational Drug 72 Chronic Lymphocytic Leukemia 72 Breast Cancers 72 Randomized Study 72 Inhaled Corticosteroids 72 Taxane 72 Phase IIb Clinical Trial 72 Cell Lymphoma 72 Irinotecan 72 Pediatric Patients 72 Patients Enrolled 72 Tyrosine Kinase Inhibitor 72 Diffuse Large B 72 Capecitabine 72 Ovarian Cancer Patients 72 Brentuximab Vedotin SGN 72 Epratuzumab 72 Demonstrates Significant 72 Lupus Nephritis 72 Pharmacokinetic Study 72 Treatment Regimen 72 Relapsed 72 Radical Prostatectomy 72 Dose Escalation 72 Malignant Glioma 72 Receives Orphan Drug Designation 72 Prophylactic Treatment 72 Novel Oral 72 Tumor Growth 72 Rectal Cancer 72 Clinical Outcome 72 Peginterferon Alfa 2a 72 Neoadjuvant Chemotherapy 72 Pegylated Liposomal Doxorubicin 72 Pemetrexed 72 Proven Effective 72 Lung Cancer Trial 71 Preclinical Data 71 Invasive Fungal Infections 71 Chemotherapy Regimen 71 Newly Diagnosed 71 Nilotinib 71 Postmenopausal Osteoporosis 71 Long Term Outcomes 71 Renal Function 71 Protease Inhibitor 71 Placebo Controlled Trial 71 Myelofibrosis 71 Drug Shows Promise 71 Lung Cancer Survival 71 Trastuzumab 71 Radiofrequency Ablation 71 Rotavirus Vaccine 71 Positive Opinion 71 Fludarabine 71 Treatment Naïve Patients 71 Tolerability 71 Oral Mucositis 71 Glufosfamide 71 Proves Effective 71 Demonstrates Efficacy 71 Pivotal Trials 71 Liver Metastases 71 Progenitor Cells 71 Significantly Reduced 71 Phase 2a Clinical Trial 71 II Clinical Trial 71 Vaccine Candidate 71 Kidney Transplant Patients 71 Fast Track Status 71 HCV Protease Inhibitor 71 Slow Progression 71 Acute Heart Failure 71 Breast Cancer Treatment 71 Ranolazine 71 Cardiovascular Outcomes 71 Randomized Double Blind 71 Efficacy Trial 71 Initiate Phase 71 Hepatitis B Vaccine 71 Oral Cladribine 71 Contrast Agents 71 Partial Onset Seizures 71 Drug Combo 71 Bone Metastases 71 Fungal Infections 71 Breast Cancer Patients 71 Diabetic Macular Edema 71 Advanced Gastric Cancer 71 Acute Myocardial Infarction 71 Neoadjuvant 70 Demonstrates Potent 70 Fracture Risk 70 Renal Cancer 70 Prospective Randomized 70 First Patient Dosed 70 SPRYCEL ® 70 Gemcitabine 70 Combination Clinical Trial 70 NDA Submission 70 Carcinoma 70 Cyclophosphamide 70 Chronic HCV 70 Patients Suffering 70 Randomized Phase II 70 Premature Infants 70 Treatment Naïve 70 Lung Cancer Drug 70 Treatment Naive HIV 70 Antiviral Activity 70 Cell Lung Cancer 70 RNAi Therapeutic 70 Metastases 70 Venous Thromboembolism 70 Controlled Trial 70 Stomach Cancer 70 Initiate Clinical Trial 70 ST Elevation Myocardial 70 Stent Restenosis 70 Bare Metal Stents 70 Phase 1b Clinical Trial 70 Renal Impairment 70 FDA Approvals 70 Kidney Transplant Recipients 70 Combo Therapy 70 Newly Diagnosed Patients 70 Shows Promising 70 Leukemias 70 Treatment Reduces 70 Prostate Cancer Vaccine 70 Efficacious 70 Teva Provides Update 70 Receives Positive Opinion 70 Confirmatory Phase 70 Gene Variant 70 Allergic Rhinitis 70 Immunosuppression 70 Platinol ® 70 Paclitaxel Carboplatin 70 Phase III Clinical Trials 70 Interferon Alfa 70 Cholesterol Lowering Drug 70 Improve Outcomes 70 Randomized Clinical Trial 70 Lupus Drug 70 Fluorouracil 70 Tiotropium 70 Stem Cell Treatment 70 Experimental Vaccine 70 Naive Patients 70 Increased Mortality 70 Granted Orphan Drug 70 Hemodialysis Patients 70 Viral Load 70 Diabetic Nephropathy 70 Active Rheumatoid Arthritis 70 Gene Linked 70 Preterm Delivery 70 Immune Responses 70 Esophageal Cancer 70 Liver Failure 70 Bortezomib 70 Cell Transplants 70 Dasatinib 70 Low Dose 70 Increased Risk 70 Stem Cell Transplants 70 Survival Rates 70 Multicenter Trial 70 Meta Analysis 70 Cancer Treatments 70 Serious Infections 70 Recurrent Breast Cancer 70 EGFR TKI 70 Paraplatin ® 70 Progressive Multifocal Leukoencephalopathy 70 Boosts Survival 70 Expanded Indication 70 Non Inferiority 70 Phase IIa Clinical Trial 70 Predict Risk 69 Tumor Cell 69 Shows Promise Against 69 Melphalan 69 Minimally Invasive Treatment 69 Renal Anemia 69 Blood Pressure Drug 69 Phase 2a Trial 69 Endometrial Cancer 69 FOLFIRI 69 Study Shows Promise 69 Peginterferon Alfa 2b 69 Pivotal Clinical Trial 69 Controlled Study 69 Hsp# Inhibitor 69 Epidermal Growth Factor Receptor 69 Randomized Trials 69 Spectrum Pharmaceuticals Announces 69 Critically Ill Patients 69 Bladder Cancer 69 Disease Modifying 69 Elevated Levels 69 Lung Cancers 69 Significantly Improved 69 dasatinib Sprycel ® 69 Tumor Progression 69 Stent Implantation 69 Left Ventricular 69 Liver Tumors 69 Interferon Beta 69 Gout Drug 69 Invasive Breast Cancer 69 Anti Tumor 69 Osteoporosis Drug 69 Erlotinib 69 Long Term Survival 69 Diabetic Neuropathy 69 Data Suggest 69 Osteoporosis Drugs 69 Interferon Gamma 69 Diabetic Neuropathic Pain 69 Demonstrate Significant 69 Carotid Stenting 69 Lowers Risk 69 5 fluorouracil leucovorin 69 Anticancer Drug 69 Treatment Shows Promise 69 Hepatitis C Genotype 69 Clinical Efficacy 69 Demonstrates Positive 69 Novel Mechanism 69 Drug Resistant 69 Juvenile Idiopathic Arthritis 69 Decitabine 69 Chronic Renal Failure 69 Successfully Treated 69 Genes Linked 69 Gastrointestinal Stromal Tumors 69 Epoetin Alfa 69 Placebo Controlled Study 69 Intravenous Formulation 69 Predict Response 69 Cognitive Impairment 69 Antiviral Drugs 69 Medullary Thyroid Cancer 69 Treatment Naive 69 Preclinical Study 69 Squamous 69 Severe Asthma 69 FDA Approves Drug 69 R lenalidomide 69 Pneumococcal Vaccine 69 Glatiramer Acetate 69 Dialysis Patients 69 Gum Disease 69 Dose Ranging Study 69 Septic Shock 69 Zoledronic Acid 69 Initiates Clinical Trial 69 Aflibercept 69 Treatment Resistant 69 Endovascular Treatment 69 Relapsed Refractory Aggressive 69 FDA Clears 69 Clostridium difficile Infection 69 Monoclonal Antibody 69 Ozarelix 69 Study Demonstrates 69 Sirolimus Eluting Stent 69 Demonstrated Significant 69 Vicriviroc 69 Targeted Therapies 69 Gastric Ulcers 69 Breast Cancer Cells 69 Potent Antiviral Activity 69 Epilepsy Drug 69 Chronic Heart Failure 69 Squamous Cell Carcinoma 69 Artery Disease 69 Patient Outcomes 69 Myelodysplastic Syndrome MDS 69 Allogeneic 68 Lymph Node 68 Osteoarthritis Patients 68 Bipolar Depression 68 Adalimumab 68 Files IND 68 alfa 2a 68 Radiofrequency Ablation RFA 68 Fondaparinux 68 Cancer Recurrence 68 Treating Heart Failure 68 Enlarged Prostate 68 Colorectal Adenomas 68 Line Metastatic Colorectal 68 Versus Placebo 68 Dual Antiplatelet Therapy 68 IND Application 68 Beneficial Effects 68 Successfully Completes Phase 68 Oral Calcitonin 68 ACE Inhibitors 68 Fixed Dose 68 Eculizumab 68 Premenopausal Women 68 refractory chronic lymphocytic 68 FDA Accepts 68 CHMP Opinion 68 Drug Eluting 68 Multicenter Randomized 68 Lenalidomide 68 Phase III Pivotal 68 Relapsed Refractory Multiple Myeloma 68 Breast Tumors 68 Genes Predict 68 Confirms Efficacy 68 Kidney Function 68 Sipuleucel T 68 Platelet Inhibition 68 Hematological Malignancies 68 Present Preclinical Data 68 Psoriasis Drug 68 Protein Linked 68 FDA Okays 68 Aliskiren 68 NICE Recommends 68 Mylan Receives Approval 68 Alemtuzumab 68 Dose Ranging 68 Kinase Inhibitor 68 Tezampanel 68 Kidney Failure 68 Double Blind Placebo 68 Aggressive Prostate Cancer 68 Adenoma 68 Chronic Lymphocytic Leukemia CLL 68 Dupuytren Contracture 68 Hypercholesterolemia 68 Non Responders 68 Drug Prevents 68 Initiates Phase 68 Bosutinib 68 Prognostic Significance 68 Mantle Cell Lymphoma 68 Increases Risk 68 Supplemental Biologics License Application 68 metastatic CRC 68 Diabetic Foot Ulcer 68 Bipolar Mania 68 Obese Patients 68 Parathyroid Hormone 68 Metastatic Pancreatic Cancer 68 Bloodstream Infections 68 Fewer Side Effects 68 Reduced Risk 68 IIa Clinical Trial 68 Benign Prostatic Hyperplasia 68 Genetic Variant 68 Gene Variation 68 Paroxysmal Atrial Fibrillation 68 Ischemic Stroke 68 Commonly Used 68 Significantly Reduces 68 Gastrointestinal Disorders 68 Chemotherapeutic Agents 68 sunitinib Sutent 68 Metastatic 68 Therapeutic Vaccine 68 Randomized Controlled Trials 68 Novel Antibiotic 68 Migraine Headaches 68 Achieves Primary Endpoint 68 Preclinical Models 68 Diabetic Foot Ulcers 68 5 FU leucovorin 68 Pirfenidone 68 Insulin Glargine 68 HDAC Inhibitor 68 Slows Progression 68 Erectile Dysfunction Drug 68 Radioimmunotherapy 68 Virus Infection 68 First Patient Enrolled 68 B Cell Lymphoma 68 Neovascular Age Related Macular 68 Antitumor 68 TORISEL 68 Blood Pressure Lowering 68 AVASTIN 68 Induction Therapy 68 Anti Clotting Drug 68 Post Operative 68 atypical Hemolytic Uremic Syndrome 68 Hospital Acquired Pneumonia 68 Clinical Trial Data 68 Total Knee Arthroplasty 68 Demonstrates Potential 68 stage IIIB 68 Arthritis Drug 68 Anti TNF 68 mCRC 68 Test Detects 68 TNF Blockers 68 Tesetaxel 68 Reduces Risk 68 Prostate Biopsy 68 ORENCIA ® 68 Secondary Hyperparathyroidism 68 Inflammatory Markers 68 FDA Clearance 68 Significantly Improves 67 Transplant Patients 67 Inhaled Nitric Oxide 67 Patient Treated 67 Golimumab 67 Poorly Controlled 67 Kinase Inhibitors 67 Balloon Angioplasty 67 Reduces Mortality 67 Randomized Clinical Trials 67 Gemzar ® 67 Ischemic 67 metastatic GIST 67 Blood Cancers 67 Acute Myeloid Leukemia 67 Myelodysplastic Syndrome 67 Less Invasive 67 Presents Preclinical Data 67 Etanercept 67 mRCC 67 Antiretroviral Therapy 67 Medoxomil 67 Systemic Sclerosis 67 Plaque Psoriasis 67 imatinib Gleevec ® 67 dependent kinase inhibitor 67 Idiopathic Pulmonary Fibrosis 67 Randomized Phase III 67 Vaginal Gel 67 Treat Anemia 67 FOLFOX6 67 Prolongs Life 67 Tumor Response 67 Oral Anticoagulant 67 Hormone Therapy 67 Left Ventricular Hypertrophy 67 Potentially Fatal 67 Initiates Phase II 67 Glioblastoma Multiforme 67 Sandostatin R 67 Desvenlafaxine Succinate 67 Mayo Clinic Study Finds 67 Protease Inhibitors 67 Submits NDA 67 Therapy Evaluation 67 Replacement Therapy 67 Initiates Phase III 67 Ebola Vaccine 67 Obesity Linked 67 Occlusive Disease 67 unresectable stage 67 Cocaine Addiction 67 Fludara ® 67 Voreloxin 67 Unstable Angina 67 Antiplatelet Therapy 67 ISTODAX ® 67 Community Acquired Pneumonia 67 Infarct 67 Hepatitis C Virus 67 Targeted Therapy 67 HCV Genotype 67 Skeletal Muscle 67 Universal Flu Vaccine 67 Bone Marrow Cells 67 Genital Herpes 67 Camptosar ® 67 docetaxel Taxotere ® 67 Nicotine Vaccine 67 Paroxysmal Nocturnal Hemoglobinuria PNH 67 Blocked Arteries 67 Cardiogenic Shock 67 FASLODEX 67 Romidepsin 67 Cholesterol Drugs 67 Statin Drugs 67 Skin Cancers 67 Severe Psoriasis 67 Unstable Angina Non 67 Sirolimus Eluting 67 Therapy Improves 67 Commence Phase 67 Estrogen Therapy 67 Higher Doses 67 invasive candidiasis 67 Abiraterone Acetate 67 Generic Version 67 Skin Structure Infections 67 PEGylated Fab fragment 67 Hematological Cancers 67 Emerging Therapies 67 Schizophrenia Drug 67 MEK Inhibitor 67 Anticancer Activity 67 Antibiotic Treatment 67 Colorectal Cancers 67 Malignancies 67 Telaprevir VX 67 Coronary Arteries 67 Skin Lesions 67 Safinamide 67 PRN FDA Approves 67 Oral Formulation 67 recurrent NSCLC 67 Migraine Pain 67 Novel Treatments 67 evaluating picoplatin 67 Drug Fails 67 Inhibits 67 Chemotherapy Induced 67 severe oral mucositis 67 Acute Myocardial 67 Pulmonary Artery 67 Topical Treatment 67 Cholesterol Levels 67 Retreatment 67 Tyrosine Kinase Inhibitors 67 Sustained Reduction 67 Nucleoside 67 Breast Density 67 Orphan Status 67 Thromboembolism 67 HRPC 67 Meet Primary Endpoint 67 Autoimmune Disease 67 ORLive Presents 67 IND Filing 67 Beta Blockers 67 Initiates Clinical 67 achieved CCyR 67 Acute Myeloid Leukemia AML 67 Demonstrates Sustained 67 Viral Infection 67 TB Vaccine 67 Prevent Stroke 67 Successfully Treats 66 Pharmacokinetics PK 66 Respiratory Syncytial Virus 66 Antipsychotic Medications 66 Bone Mineral Density 66 TO AVOID PREGNANCY WHILE 66 Lung Tumors 66 Effectively Treats 66 Amrubicin 66 Immune Cells 66 Physical Function 66 Milestone Payment 66 interferon gamma 1b 66 Neuroprotective Effects 66 ARIXTRA R 66 Atopic Dermatitis 66 Autoimmune Disorders 66 Interferon Alpha 66 Clinically Significant 66 metastatic colorectal carcinoma 66 Kidney Transplants 66 Allergic Asthma 66 Non Alcoholic Fatty 66 Kidney Stones 66 Cloretazine ® 66 Drug Resistant TB 66 Newly Diagnosed Breast Cancer 66 Prognostic Factors 66 Pralatrexate 66 Dapagliflozin 66 Cardiovascular Disease Risk 66 Patent Covering 66 ribavirin Copegus ® 66 5 Fluorouracil 66 ST Segment Elevation 66 Randomized Controlled 66 Anticoagulant 66 Malaria Vaccine 66 Boceprevir 66 Presents Positive 66 metastatic renal cell carcinoma 66 Bivalirudin 66 Peginterferon alfa 2b 66 metastatic malignant 66 Gene Mutations 66 cell lymphoma CTCL 66 Intracerebral Hemorrhage 66 CYT# potent vascular disrupting 66 stage IIIb IV 66 STELARA TM 66 PEGINTRON TM 66 Liver Cancer 66 familial amyloidotic polyneuropathy FAP 66 Taxotere ® 66 erlotinib Tarceva ® 66 First Patient Treated 66 SCCHN 66 Diuretic 66 Nebulized 66 Pregnancy Linked 66 Xenografts 66 Tumor Targeting 66 Genes Associated 66 FDA Approves 66 Prostate Cancer Treatment 66 Chronic Bronchitis 66 R Bortezomib 66 Prolonged Survival 66 Pafuramidine 66 Clinical Outcomes 66 Lubiprostone 66 Bavituximab 66 ara C 66 Sevelamer 66 Lymph Nodes 66 Acute Coronary Syndromes 66 Surgical Treatment 66 Albuferon TM 66 Mouse Models 66 See CLINICAL PHARMACOLOGY 66 Myocardial Ischemia 66 Regimens 66 Xelox 66 Reduced Incidence 66 Drug Coated Stents 66 Therapy Shows Promise 66 Sapacitabine 66 Catheter Ablation 66 Coronary Artery 66 Receives FDA Clearance 66 Ofatumumab 66 Enzyme Replacement Therapy 66 Antibiotic Use 66 Eluting Stent 66 Symptom Relief 66 Vandetanib 66 C1 Inhibitor 66 Antiviral Therapy 66 Subtypes 66 Vaccine Adjuvant 66 Perifosine KRX 66 Shows Promise 66 Humanized Anti 66 Methylnaltrexone 66 Atypical Antipsychotic 66 Osteoporosis Treatment 66 HER2 positive metastatic breast 66 Pegylated 66 Induces 66 Therapy Reduces 66 metastatic castration resistant 66 Hemoglobin Levels 66 Hepatitis B Virus 66 dual endothelin receptor antagonist 66 Endothelial Cells 66 Induction Chemotherapy 66 Immunosuppressant 66 Rheumatoid Arthritis Drug 66 Bazedoxifene 66 Genetic Tests 66 cancer mCRC 66 Azacitidine 66 Anti Inflammatory Drug 66 Renal Tumors 66 Multicenter Phase 66 Postherpetic Neuralgia 66 Seasonal Influenza Vaccine 66 Lung Function 66 Prostate Cancers 66 Antigen Specific 66 assessing T DM1 66 Apaziquone 66 Commonly Prescribed 66 Pazopanib 66 Phase III Pivotal Trial 66 JAK2 Inhibitor 66 Cancer Cells 66 Transdermal Patch 66 Viral Suppression 66 Therapeutic Potential 66 Recurrent Ovarian Cancer 66 relapsing remitting MS RRMS 66 receptor tyrosine kinase inhibitor 66 Bacterial Infections 66 Inflammatory Arthritis 66 Carcinomas 66 Dendritic Cells 66 Non Invasive Treatment 66 Malignant Pleural Mesothelioma 66 Uterine Fibroid Embolization 66 Lung Injury 66 Vaccine Protects Against 66 Tigecycline 66 Blood Transfusions 66 Anticancer Drugs 66 Blood Clots 66 Recombinant Human 66 Nymox NX 66 Psoriasis Patients 66 Novel Inhibitor 66 Smallpox Vaccine 66 Topline Results 66 Therapeutic Efficacy 66 Stereotactic Body Radiation Therapy 66 Demonstrates Statistically Significant 66 Urinary Incontinence 66 Restenosis 66 Prostate Tumors 66 Insulin Resistance 66 DOXIL 66 Urinary Tract Infections 66 Epilepsy Drugs 66 Viral Infections 66 Orally Active 66 Tumor Cells 66 Cholesterol Drug 66 Shows Statistically Significant 66 Docetaxel 66 Inherited Diseases 66 Respiratory Distress 66 Radiation Induced 66 Advaxis Phase 66 bone marrow reticulin deposition 66 Severe Acne 66 Vildagliptin 66 Effective Than 66 CTAP# Capsules 66 Significant Reduction 66 Surgery Performed 66 Cardiotoxicity 66 REVLIMID R 66 pegylated liposomal doxorubicin 66 Metastatic Disease 66 Phase Ib Clinical Trial 66 Brain Atrophy 66 Renal Artery 66 Tacrolimus 66 Natalizumab 66 Mesothelioma Treatment 66 Chronic Constipation 66 relapsed MM 66 Immune Cell 66 stage IIIb 66 Efficacy Results 66 Ovarian Cancers 66 Tocilizumab 66 Neoplasms 66 PKC# 66 Genetic Variants 66 Hematopoietic Stem Cell Transplantation 66 Hemorrhagic Stroke 66 Vitro Activity 65 Thyroid Cancer 65 ACTEMRA TM 65 Atypical Antipsychotics 65 Corticosteroid 65 Levels Linked 65 Acute Pancreatitis 65 Adverse Effects 65 NAVISTAR R 65 Pertuzumab 65 Drug Eluting Stent 65 Migraine Drug 65 Virus Linked 65 Spinal Fusion 65 Valsartan 65 Randomized Controlled Trial 65 Genasense R 65 Microplasmin 65 Autoimmune Diseases 65 Chronic Myelogenous Leukemia 65 Gentium Announces 65 Metabolic Efficiency 65 Rituximab 65 TAXOTERE R 65 pan HDAC inhibitor 65 XYOTAX TM 65 Respiratory Virus 65 Inflammatory Diseases 65 Recurrent Stroke 65 Prophylaxis 65 Retinal Vein Occlusion 65 Cognitive Decline 65 Temsirolimus 65 Cancer Patients Treated 65 Genes Identified 65 Who Underwent 65 sorafenib Nexavar 65 Prognostic Value 65 Enoxaparin 65 Depressive Symptoms 65 sunitinib Sutent ® 65 Circulating Tumor Cells 65 Bacterial Infection 65 Interferon beta 1a 65 Study Shows Benefits 65 Shingles Vaccine 65 Surgical Procedures 65 Blood Thinner 65 Oral Cavity 65 Chronic Inflammation 65 Prostatectomy 65 Lymphocytic 65 ThermoDox R 65 Reduce Mortality 65 Intracranial Aneurysms 65 Molecular Diagnostic Test 65 Hepatocellular 65 metastatic colorectal 65 Completes Dosing 65 Cardiac Resynchronization 65 Immunomedics Announces 65 Asthma Treatment 65 Palifosfamide 65 Carboplatin 65 Immunogenicity 65 mapatumumab 65 FUSILEV enhances 65 Newly Diagnosed Chronic Myeloid 65 Initiated Phase 65 Initiates Enrollment 65 Seasonal Allergies 65 Genetic Disorder 65 Remission Maintenance 65 INTEGRILIN R 65 TYKERB 65 Asthma Symptoms 65 thalidomide Thalomid 65 Showed Significant 65 Venous Thrombosis 65 Hepatocellular Carcinoma HCC 65 Copegus ribavirin 65 carcinoma mCRC 65 Genetic Mutations 65 Posaconazole 65 biliary tract cancer 65 Peripheral Blood 65 Reduces Pain 65 bevacizumab Avastin ® 65 Doxorubicin 65 Cethromycin 65 Drug Regimen 65 Predict Breast Cancer 65 sorafenib tablets 65 Preterm Infants 65 Neuroendocrine Tumors 65 MGd 65 Generalized Anxiety Disorder 65 Sustained Virologic Response 65 metastatic hormone refractory 65 Omacetaxine 65 Seasonal Allergic Rhinitis